Bio

Mr. Healy is a Vice President at RoundTable, working with the Pharmaceuticals & Consumer Health team. In this role, he focuses on the identification, evaluation, and execution of new platform investments and portfolio company add-on transactions. Mr. Healy currently works with RoundTable’s investments in Revision Skincare / Goodier Cosmetics and Renaissance. He has also supported the firm’s investments in Santa Cruz Nutritionals, Symmetry Surgical, and SunMed. Before joining RoundTable, Mr. Healy was an Analyst in the Global Industrials Group at Deutsche Bank Securities.